{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T02:38:50Z","timestamp":1789180730211,"version":"build-2803163510"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2013,11,6]],"date-time":"2013-11-06T00:00:00Z","timestamp":1383696000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pflugers Arch - Eur J Physiol"],"DOI":"10.1007\/s00424-013-1394-x","type":"journal-article","created":{"date-parts":[[2013,11,5]],"date-time":"2013-11-05T09:48:51Z","timestamp":1383644931000},"source":"Crossref","is-referenced-by-count":9,"title":["Polycystin-1 but not polycystin-2 deficiency causes upregulation of the mTOR pathway and can be synergistically targeted with rapamycin and metformin"],"prefix":"10.1007","author":[{"given":"Djalila","family":"Mekahli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Paul","family":"Decuypere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Sammels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"Welkenhuyzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost","family":"Schoeber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Pierre","family":"Audrezet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anniek","family":"Corvelyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georges","family":"Dech\u00eanes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert C. M.","family":"Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martijn J.","family":"Wilmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lambertus","family":"van den Heuvel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geert","family":"Bultynck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan B.","family":"Parys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludwig","family":"Missiaen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Levtchenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Humbert","family":"De Smedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,11,6]]},"reference":[{"key":"1394_CR1","doi-asserted-by":"crossref","unstructured":"Audrezet MP, Cornec-Le Gall E, Chen JM, Redon S, Quere I, Creff J, Benech C, Maestri S, Le Meur Y, Ferec C (2012) Autosomal dominant polycystic kidney disease: comprehensive mutation analysis of PKD1 and PKD2 in 700 unrelated patients. Hum Mutat 33(8):1239\u20131250","DOI":"10.1002\/humu.22103"},{"issue":"8","key":"1394_CR2","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1681\/ASN.2009020162","volume":"20","author":"M Barua","year":"2009","unstructured":"Barua M, Cil O, Paterson AD, Wang K, He N, Dicks E, Parfrey P, Pei Y (2009) Family history of renal disease severity predicts the mutated gene in ADPKD. J Am Soc Nephrol 20(8):1833\u20131838","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"1394_CR3","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1755-8417-2-6","volume":"2","author":"A Boletta","year":"2009","unstructured":"Boletta A (2009) Emerging evidence of a link between the polycystins and the mTOR pathways. Pathogenetics 2(1):6","journal-title":"Pathogenetics"},{"key":"1394_CR4","doi-asserted-by":"crossref","unstructured":"Canaud G, Knebelmann B, Harris PC, Vrtovsnik F, Correas JM, Pallet N, Heyer CM, Letavernier E, Bienaime F, Thervet E, Martinez F, Terzi F, Legendre C (2010) Therapeutic mTOR inhibition in autosomal dominant polycystic kidney disease: what is the appropriate serum level? Am J Transplant 10(7):1701\u20131706","DOI":"10.1111\/j.1600-6143.2010.03152.x"},{"issue":"1","key":"1394_CR5","doi-asserted-by":"crossref","first-page":"c25","DOI":"10.1159\/000334166","volume":"120","author":"MY Chang","year":"2012","unstructured":"Chang MY, Ong AC (2012) Mechanism-based therapeutics for autosomal dominant polycystic kidney disease: recent progress and future prospects. Nephron Clin Pract 120(1):c25\u201334, discussion c35","journal-title":"Nephron Clin Pract"},{"issue":"3","key":"1394_CR6","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1046\/j.1523-1755.2003.00185.x","volume":"64","author":"AB Chapman","year":"2003","unstructured":"Chapman AB, Guay-Woodford LM, Grantham JJ, Torres VE, Bae KT, Baumgarten DA, Kenney PJ, King BF Jr, Glockner JF, Wetzel LH, Brummer ME, O'Neill WC, Robbin ML, Bennett WM, Klahr S, Hirschman GH, Kimmel PL, Thompson PA, Miller JP (2003) Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort. Kidney Int 64(3):1035\u20131045","journal-title":"Kidney Int"},{"issue":"6","key":"1394_CR7","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/j.1399-0004.2006.00721.x","volume":"70","author":"W Chung","year":"2006","unstructured":"Chung W, Kim H, Hwang YH, Kim SY, Ko AR, Ro H, Lee KB, Lee JS, Oh KH, Ahn C (2006) PKD2 gene mutation analysis in Korean autosomal dominant polycystic kidney disease patients using two-dimensional gene scanning. Clin Genet 70(6):502\u2013508","journal-title":"Clin Genet"},{"issue":"9","key":"1394_CR8","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1128\/MCB.01259-08","volume":"29","author":"G Distefano","year":"2009","unstructured":"Distefano G, Boca M, Rowe I, Wodarczyk C, Ma L, Piontek KB, Germino GG, Pandolfi PP, Boletta A (2009) Polycystin-1 regulates extracellular signal-regulated kinase-dependent phosphorylation of tuberin to control cell size through mTOR and its downstream effectors S6K and 4EBP1. Mol Cell Biol 29(9):2359\u20132371","journal-title":"Mol Cell Biol"},{"issue":"6","key":"1394_CR9","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.2337\/dc09-1284","volume":"33","author":"A Frid","year":"2010","unstructured":"Frid A, Sterner GN, Londahl M, Wiklander C, Cato A, Vinge E, Andersson A (2010) Novel assay of metformin levels in patients with type 2 diabetes and varying levels of renal function: clinical recommendations. Diabetes Care 33(6):1291\u20131293","journal-title":"Diabetes Care"},{"issue":"7","key":"1394_CR10","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1038\/emboj.2010.18","volume":"29","author":"A Giamarchi","year":"2010","unstructured":"Giamarchi A, Feng S, Rodat-Despoix L, Xu Y, Bubenshchikova E, Newby LJ, Hao J, Gaudioso C, Crest M, Lupas AN, Honore E, Williamson MP, Obara T, Ong AC, Delmas P (2010) A polycystin-2 (TRPP2) dimerization domain essential for the function of heteromeric polycystin complexes. EMBO J 29(7):1176\u20131191","journal-title":"EMBO J"},{"issue":"3","key":"1394_CR11","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1056\/NEJMc1010845","volume":"364","author":"JJ Grantham","year":"2011","unstructured":"Grantham JJ, Bennett WM, Perrone RD (2011) mTOR inhibitors and autosomal dominant polycystic kidney disease. N Engl J Med 364(3):286\u2013287, author reply 287\u2013289","journal-title":"N Engl J Med"},{"issue":"20","key":"1394_CR12","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1056\/NEJMoa054341","volume":"354","author":"JJ Grantham","year":"2006","unstructured":"Grantham JJ, Torres VE, Chapman AB, Guay-Woodford LM, Bae KT, King BF Jr, Wetzel LH, Baumgarten DA, Kenney PJ, Harris PC, Klahr S, Bennett WM, Hirschman GN, Meyers CM, Zhang X, Zhu F, Miller JP (2006) Volume progression in polycystic kidney disease. N Engl J Med 354(20):2122\u20132130","journal-title":"N Engl J Med"},{"issue":"12","key":"1394_CR13","doi-asserted-by":"crossref","first-page":"958","DOI":"10.18632\/oncotarget.381","volume":"2","author":"SL Habib","year":"2011","unstructured":"Habib SL (2011) Mechanism of activation of AMPK and upregulation of OGG1 by rapamycin in cancer cells. Oncotarget 2(12):958\u2013959","journal-title":"Oncotarget"},{"key":"1394_CR14","doi-asserted-by":"crossref","unstructured":"Habib SL, Kasinath BS, Arya RR, Vexler S, Velagapudi C (2010) Novel mechanism of reducing tumourigenesis: upregulation of the DNA repair enzyme OGG1 by rapamycin-mediated AMPK activation and mTOR inhibition. Eur J Cancer 46(15):2806\u20132820","DOI":"10.1016\/j.ejca.2010.06.117"},{"issue":"6815","key":"1394_CR15","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1038\/35050128","volume":"408","author":"K Hanaoka","year":"2000","unstructured":"Hanaoka K, Qian F, Boletta A, Bhunia AK, Piontek K, Tsiokas L, Sukhatme VP, Guggino WB, Germino GG (2000) Co-assembly of polycystin-1 and -2 produces unique cation-permeable currents. Nature 408(6815):990\u2013994","journal-title":"Nature"},{"issue":"11","key":"1394_CR16","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1681\/ASN.2006080835","volume":"17","author":"PC Harris","year":"2006","unstructured":"Harris PC, Bae KT, Rossetti S, Torres VE, Grantham JJ, Chapman AB, Guay-Woodford LM, King BF, Wetzel LH, Baumgarten DA, Kenney PJ, Consugar M, Klahr S, Bennett WM, Meyers CM, Zhang QJ, Thompson PA, Zhu F, Miller JP (2006) Cyst number but not the rate of cystic growth is associated with the mutated gene in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 17(11):3013\u20133019","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"1394_CR17","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/hmg\/ddn325","volume":"18","author":"TR Hartman","year":"2009","unstructured":"Hartman TR, Liu D, Zilfou JT, Robb V, Morrison T, Watnick T, Henske EP (2009) The tuberous sclerosis proteins regulate formation of the primary cilium via a rapamycin-insensitive and polycystin 1-independent pathway. Hum Mol Genet 18(1):151\u2013163","journal-title":"Hum Mol Genet"},{"issue":"9147","key":"1394_CR18","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0140-6736(98)03495-3","volume":"353","author":"N Hateboer","year":"1999","unstructured":"Hateboer N, Van Dijk MA, Bogdanova N, Coto E, Saggar-Malik AK, San Millan JL, Torra R, Breuning M, Ravine D (1999) Comparison of phenotypes of polycystic kidney disease types 1 and 2. European PKD1-PKD2 Study Group. Lancet 353(9147):103\u2013107","journal-title":"Lancet"},{"issue":"2","key":"1394_CR19","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1042\/BJ20080281","volume":"412","author":"J Huang","year":"2008","unstructured":"Huang J, Manning BD (2008) The TSC1\u2013TSC2 complex: a molecular switchboard controlling cell growth. Biochem J 412(2):179\u2013190","journal-title":"Biochem J"},{"issue":"3","key":"1394_CR20","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.cmpb.2006.11.004","volume":"85","author":"S Iyer","year":"2007","unstructured":"Iyer S, Deutsch K, Yan X, Lin B (2007) Batch RNAi selector: a standalone program to predict specific siRNA candidates in batches with enhanced sensitivity. Comput Methods Programs Biomed 85(3):203\u2013209","journal-title":"Comput Methods Programs Biomed"},{"issue":"8","key":"1394_CR21","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1432-0436.2005.00048.x","volume":"73","author":"C Karcher","year":"2005","unstructured":"Karcher C, Fischer A, Schweickert A, Bitzer E, Horie S, Witzgall R, Blum M (2005) Lack of a laterality phenotype in Pkd1 knock-out embryos correlates with absence of polycystin-1 in nodal cilia. Differentiation 73(8):425\u2013432","journal-title":"Differentiation"},{"issue":"301","key":"1394_CR22","first-page":"301","volume":"303","author":"W Lieberthal","year":"2012","unstructured":"Lieberthal W, Levine JS (2012) Mammalian target of rapamycin and the kidney part I: the signaling pathway. Am J Physiol Renal Physiol 303(301):301\u2013310","journal-title":"Am J Physiol Renal Physiol"},{"issue":"302","key":"1394_CR23","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1152\/ajprenal.00015.2012","volume":"303","author":"W Lieberthal","year":"2012","unstructured":"Lieberthal W, Levine JS (2012) Mammalian target of rapamycin and the kidney part II: pathophysiology and therapeutic implications. Am J Physiol Renal Physiol 303(302):180\u2013391","journal-title":"Am J Physiol Renal Physiol"},{"issue":"6","key":"1394_CR24","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.2337\/dc10-2361","volume":"34","author":"KJ Lipska","year":"2011","unstructured":"Lipska KJ, Bailey CJ, Inzucchi SE (2011) Use of metformin in the setting of mild-to-moderate renal insufficiency. Diabetes Care 34(6):1431\u20131437","journal-title":"Diabetes Care"},{"issue":"6","key":"1394_CR25","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.mehy.2009.05.043","volume":"73","author":"MF McCarty","year":"2009","unstructured":"McCarty MF, Barroso-Aranda J, Contreras F (2009) Activation of AMP-activated kinase as a strategy for managing autosomal dominant polycystic kidney disease. Med Hypotheses 73(6):1008\u20131010","journal-title":"Med Hypotheses"},{"issue":"6","key":"1394_CR26","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.ceca.2012.03.002","volume":"51","author":"D Mekahli","year":"2012","unstructured":"Mekahli D, Sammels E, Luyten T, Welkenhuyzen K, van den Heuvel LP, Levtchenko EN, Gijsbers R, Bultynck G, Parys JB, De Smedt H, Missiaen L (2012) Polycystin-1 and polycystin-2 are both required to amplify inositol-trisphosphate-induced Ca(2+) release. Cell Calcium 51(6):452\u2013458","journal-title":"Cell Calcium"},{"issue":"5","key":"1394_CR27","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1681\/ASN.2011040340","volume":"23","author":"Z Novalic","year":"2012","unstructured":"Novalic Z, van der Wal AM, Leonhard WN, Koehl G, Breuning MH, Geissler EK, de Heer E, Peters DJ (2012) Dose-dependent effects of sirolimus on mTOR signaling and polycystic kidney disease. J Am Soc Nephrol 23(5):842\u2013853","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"1394_CR28","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1046\/j.1523-1755.1999.00404.x","volume":"55","author":"AC Ong","year":"1999","unstructured":"Ong AC, Harris PC, Biddolph S, Bowker C, Ward CJ (1999) Characterisation and expression of the PKD-1 protein, polycystin, in renal and extrarenal tissues. Kidney Int 55(5):2091\u20132116","journal-title":"Kidney Int"},{"issue":"4","key":"1394_CR29","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1046\/j.1523-1755.1999.00659.x","volume":"56","author":"AC Ong","year":"1999","unstructured":"Ong AC, Harris PC, Davies DR, Pritchard L, Rossetti S, Biddolph S, Vaux DJ, Migone N, Ward CJ (1999) Polycystin-1 expression in PKD1, early-onset PKD1, and TSC2\/PKD1 cystic tissue. Kidney Int 56(4):1324\u20131333","journal-title":"Kidney Int"},{"issue":"6","key":"1394_CR30","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1016\/S0002-9440(10)65428-4","volume":"154","author":"AC Ong","year":"1999","unstructured":"Ong AC, Ward CJ, Butler RJ, Biddolph S, Bowker C, Torra R, Pei Y, Harris PC (1999) Coordinate expression of the autosomal dominant polycystic kidney disease proteins, polycystin-2 and polycystin-1, in normal and cystic tissue. Am J Pathol 154(6):1721\u20131729","journal-title":"Am J Pathol"},{"issue":"6","key":"1394_CR31","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1086\/515467","volume":"60","author":"B Peral","year":"1997","unstructured":"Peral B, Gamble V, Strong C, Ong AC, Sloane-Stanley J, Zerres K, Winearls CG, Harris PC (1997) Identification of mutations in the duplicated region of the polycystic kidney disease 1 gene (PKD1) by a novel approach. Am J Hum Genet 60(6):1399\u20131410","journal-title":"Am J Hum Genet"},{"issue":"12","key":"1394_CR32","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/nrneph.2010.153","volume":"6","author":"N Perico","year":"2010","unstructured":"Perico N, Remuzzi G (2010) Do mTOR inhibitors still have a future in ADPKD? Nat Rev Nephrol 6(12):696\u2013698","journal-title":"Nat Rev Nephrol"},{"issue":"6","key":"1394_CR33","doi-asserted-by":"crossref","first-page":"R149","DOI":"10.1186\/cc7137","volume":"12","author":"N Peters","year":"2008","unstructured":"Peters N, Jay N, Barraud D, Cravoisy A, Nace L, Bollaert PE, Gibot S (2008) Metformin-associated lactic acidosis in an intensive care unit. Crit Care 12(6):R149","journal-title":"Crit Care"},{"issue":"12","key":"1394_CR34","doi-asserted-by":"crossref","first-page":"3809","DOI":"10.1093\/ndt\/gfq527","volume":"25","author":"C Ponticelli","year":"2010","unstructured":"Ponticelli C, Locatelli F (2010) Autosomal dominant polycystic kidney disease and mTOR inhibitors: the narrow road between hope and disappointment. Nephrol Dial Transplant 25(12):3809\u20133812","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"1394_CR35","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/ng0697-179","volume":"16","author":"F Qian","year":"1997","unstructured":"Qian F, Germino FJ, Cai Y, Zhang X, Somlo S, Germino GG (1997) PKD1 interacts with PKD2 through a probable coiled-coil domain. Nat Genet 16(2):179\u2013183","journal-title":"Nat Genet"},{"issue":"3","key":"1394_CR36","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1681\/ASN.2007050626","volume":"19","author":"Q Qian","year":"2008","unstructured":"Qian Q, Du H, King BF, Kumar S, Dean PG, Cosio FG, Torres VE (2008) Sirolimus reduces polycystic liver volume in ADPKD patients. J Am Soc Nephrol 19(3):631\u2013638","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"1394_CR37","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1086\/301600","volume":"61","author":"JH Roelfsema","year":"1997","unstructured":"Roelfsema JH, Spruit L, Saris JJ, Chang P, Pirson Y, van Ommen GJ, Peters DJ, Breuning MH (1997) Mutation detection in the repeated part of the PKD1 gene. Am J Hum Genet 61(5):1044\u20131052","journal-title":"Am J Hum Genet"},{"issue":"5","key":"1394_CR38","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1681\/ASN.2011101032","volume":"23","author":"S Rossetti","year":"2012","unstructured":"Rossetti S, Hopp K, Sikkink RA, Sundsbak JL, Lee YK, Kubly V, Eckloff BW, Ward CJ, Winearls CG, Torres VE, Harris PC (2012) Identification of gene mutations in autosomal dominant polycystic kidney disease through targeted resequencing. J Am Soc Nephrol 23(5):915\u2013933","journal-title":"J Am Soc Nephrol"},{"issue":"24","key":"1394_CR39","doi-asserted-by":"crossref","first-page":"18794","DOI":"10.1074\/jbc.M109.090662","volume":"285","author":"E Sammels","year":"2010","unstructured":"Sammels E, Devogelaere B, Mekahli D, Bultynck G, Missiaen L, Parys JB, Cai Y, Somlo S, De Smedt H (2010) Polycystin-2 activation by inositol 1,4,5-trisphosphate-induced Ca2+ release requires its direct association with the inositol 1,4,5-trisphosphate receptor in a signaling microdomain. J Biol Chem 285(24):18794\u201318805","journal-title":"J Biol Chem"},{"issue":"6","key":"1394_CR40","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.ceb.2005.09.009","volume":"17","author":"DD Sarbassov","year":"2005","unstructured":"Sarbassov DD, Ali SM, Sabatini DM (2005) Growing roles for the mTOR pathway. Curr Opin Cell Biol 17(6):596\u2013603","journal-title":"Curr Opin Cell Biol"},{"issue":"6","key":"1394_CR41","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1681\/ASN.2010030262","volume":"21","author":"RW Schrier","year":"2010","unstructured":"Schrier RW (2010) Randomized intervention studies in human polycystic kidney and liver disease. J Am Soc Nephrol 21(6):891\u2013893","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"1394_CR42","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1056\/NEJMoa0907419","volume":"363","author":"AL Serra","year":"2010","unstructured":"Serra AL, Poster D, Kistler AD, Krauer F, Raina S, Young J, Rentsch KM, Spanaus KS, Senn O, Kristanto P, Scheffel H, Weishaupt D, Wuthrich RP (2010) Sirolimus and kidney growth in autosomal dominant polycystic kidney disease. N Engl J Med 363(9):820\u2013829","journal-title":"N Engl J Med"},{"issue":"1","key":"1394_CR43","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1748-1716.2009.01972.x","volume":"196","author":"RJ Shaw","year":"2009","unstructured":"Shaw RJ (2009) LKB1 and AMP-activated protein kinase control of mTOR signalling and growth. Acta Physiol (Oxf) 196(1):65\u201380","journal-title":"Acta Physiol (Oxf)"},{"issue":"14","key":"1394_CR44","doi-asserted-by":"crossref","first-page":"5466","DOI":"10.1073\/pnas.0509694103","volume":"103","author":"JM Shillingford","year":"2006","unstructured":"Shillingford JM, Murcia NS, Larson CH, Low SH, Hedgepeth R, Brown N, Flask CA, Novick AC, Goldfarb DA, Kramer-Zucker A, Walz G, Piontek KB, Germino GG, Weimbs T (2006) The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease. Proc Natl Acad Sci U S A 103(14):5466\u20135471","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"1394_CR45","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1681\/ASN.2009040421","volume":"21","author":"JM Shillingford","year":"2010","unstructured":"Shillingford JM, Piontek KB, Germino GG, Weimbs T (2010) Rapamycin ameliorates PKD resulting from conditional inactivation of Pkd1. J Am Soc Nephrol 21(3):489\u2013497","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"1394_CR46","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1073\/pnas.1011498108","volume":"108","author":"V Takiar","year":"2011","unstructured":"Takiar V, Nishio S, Seo-Mayer P, King JD Jr, Li H, Zhang L, Karihaloo A, Hallows KR, Somlo S, Caplan MJ (2011) Activating AMP-activated protein kinase (AMPK) slows renal cystogenesis. Proc Natl Acad Sci U S A 108(6):2462\u20132467","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1394_CR47","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1681\/ASN.2004080660","volume":"16","author":"Y Tao","year":"2005","unstructured":"Tao Y, Kim J, Schrier RW, Edelstein CL (2005) Rapamycin markedly slows disease progression in a rat model of polycystic kidney disease. J Am Soc Nephrol 16(1):46\u201351","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"1394_CR48","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1053\/ajkd.2000.17619","volume":"36","author":"R Torra","year":"2000","unstructured":"Torra R, Badenas C, Perez-Oller L, Luis J, Millan S, Nicolau C, Oppenheimer F, Mila M, Darnell A (2000) Increased prevalence of polycystic kidney disease type 2 among elderly polycystic patients. Am J Kidney Dis 36(4):728\u2013734","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"1394_CR49","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/ki.2009.128","volume":"76","author":"VE Torres","year":"2009","unstructured":"Torres VE, Harris PC (2009) Autosomal dominant polycystic kidney disease: the last 3\u00a0years. Kidney Int 76(2):149\u2013168","journal-title":"Kidney Int"},{"issue":"3","key":"1394_CR50","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1093\/ndt\/gfi181","volume":"21","author":"PR Wahl","year":"2006","unstructured":"Wahl PR, Serra AL, Le Hir M, Molle KD, Hall MN, Wuthrich RP (2006) Inhibition of mTOR with sirolimus slows disease progression in Han:SPRD rats with autosomal dominant polycystic kidney disease (ADPKD). Nephrol Dial Transplant 21(3):598\u2013604","journal-title":"Nephrol Dial Transplant"},{"issue":"9","key":"1394_CR51","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1056\/NEJMoa1003491","volume":"363","author":"G Walz","year":"2010","unstructured":"Walz G, Budde K, Mannaa M, Nurnberger J, Wanner C, Sommerer C, Kunzendorf U, Banas B, Horl WH, Obermuller N, Arns W, Pavenstadt H, Gaedeke J, Buchert M, May C, Gschaidmeier H, Kramer S, Eckardt KU (2010) Everolimus in patients with autosomal dominant polycystic kidney disease. N Engl J Med 363(9):830\u2013840","journal-title":"N Engl J Med"},{"issue":"9","key":"1394_CR52","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1056\/NEJMe1006925","volume":"363","author":"T Watnick","year":"2010","unstructured":"Watnick T, Germino GG (2010) mTOR inhibitors in polycystic kidney disease. N Engl J Med 363(9):879\u2013881","journal-title":"N Engl J Med"},{"issue":"2","key":"1394_CR53","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00441-009-0882-y","volume":"339","author":"MJ Wilmer","year":"2010","unstructured":"Wilmer MJ, Saleem MA, Masereeuw R, Ni L, van der Velden TJ, Russel FG, Mathieson PW, Monnens LA, van den Heuvel LP, Levtchenko EN (2010) Novel conditionally immortalized human proximal tubule cell line expressing functional influx and efflux transporters. Cell Tissue Res 339(2):449\u2013457","journal-title":"Cell Tissue Res"},{"issue":"2","key":"1394_CR54","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0092-8674(00)81570-6","volume":"93","author":"G Wu","year":"1998","unstructured":"Wu G, D'Agati V, Cai Y, Markowitz G, Park JH, Reynolds DM, Maeda Y, Le TC, Hou H Jr, Kucherlapati R, Edelmann W, Somlo S (1998) Somatic inactivation of Pkd2 results in polycystic kidney disease. Cell 93(2):177\u2013188","journal-title":"Cell"},{"issue":"6","key":"1394_CR55","doi-asserted-by":"crossref","first-page":"F1597","DOI":"10.1152\/ajprenal.00430.2009","volume":"297","author":"M Wu","year":"2009","unstructured":"Wu M, Arcaro A, Varga Z, Vogetseder A, Le Hir M, Wuthrich RP, Serra AL (2009) Pulse mTOR inhibitor treatment effectively controls cyst growth but leads to severe parenchymal and glomerular hypertrophy in rat polycystic kidney disease. Am J Physiol Renal Physiol 297(6):F1597\u20131605","journal-title":"Am J Physiol Renal Physiol"},{"issue":"3","key":"1394_CR56","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.cell.2006.01.016","volume":"124","author":"S Wullschleger","year":"2006","unstructured":"Wullschleger S, Loewith R, Hall MN (2006) TOR signaling in growth and metabolism. Cell 124(3):471\u2013484","journal-title":"Cell"},{"issue":"28","key":"1394_CR57","doi-asserted-by":"crossref","first-page":"11558","DOI":"10.1073\/pnas.0903684106","volume":"106","author":"Y Yu","year":"2009","unstructured":"Yu Y, Ulbrich MH, Li MH, Buraei Z, Chen XZ, Ong AC, Tong L, Isacoff EY, Yang J (2009) Structural and molecular basis of the assembly of the TRPP2\/PKD1 complex. Proc Natl Acad Sci U S A 106(28):11558\u201311563","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"1394_CR58","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1093\/ndt\/gfp129","volume":"24","author":"I Zafar","year":"2009","unstructured":"Zafar I, Belibi FA, He Z, Edelstein CL (2009) Long-term rapamycin therapy in the Han:SPRD rat model of polycystic kidney disease (PKD). Nephrol Dial Transplant 24(8):2349\u20132353","journal-title":"Nephrol Dial Transplant"},{"key":"1394_CR59","doi-asserted-by":"crossref","unstructured":"Zafar I, Ravichandran K, Belibi FA, Doctor RB, Edelstein CL (2010) Sirolimus attenuates disease progression in an orthologous mouse model of human autosomal dominant polycystic kidney disease. Kidney Int 78(8):754\u2013761","DOI":"10.1038\/ki.2010.250"}],"container-title":["Pfl\u00fcgers Archiv - European Journal of Physiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00424-013-1394-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00424-013-1394-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00424-013-1394-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T20:57:12Z","timestamp":1559077032000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00424-013-1394-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,6]]},"references-count":59,"alternative-id":["1394"],"URL":"https:\/\/doi.org\/10.1007\/s00424-013-1394-x","relation":{},"ISSN":["0031-6768","1432-2013"],"issn-type":[{"value":"0031-6768","type":"print"},{"value":"1432-2013","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,6]]}}}